1. Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients. (2nd September 2021) Authors: Chanchlani, Neil; Lin, Simeng; Chee, Desmond; Hamilton, Benjamin; Nice, Rachel; Arkir, Zehra; Bewshea, Claire; Cipriano, Bessie; Derikx, Lauranne A A P; Dunlop, Allan; Greathead, Louise; Griffiths, Rachel L; Ibraheim, Hajir; Kelleher, Peter; Kok, Klaartje B; Lees, Charlie W; MacDonald, Jonathan; ... Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 3(2022) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Issue 2 (February 2022) Authors: Toback, Seth; Galiza, Eva; Cosgrove, Catherine; Galloway, James; Goodman, Anna L; Swift, Pauline A; Rajaram, Sankarasubramanian; Graves-Jones, Alison; Edelman, Jonathan; Burns, Fiona; Minassian, Angela M; Cho, Iksung; Kumar, Lakshmi; Plested, Joyce S; Rivers, E Joy; Robertson, Andreana; Dubovsky,... Journal: Lancet Issue: Volume 10:Issue 2(2022) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Powered by change : how to design your business for perpetual success /: how to design your business for perpetual success. (2018) Authors: MacDonald, Jonathan Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. (April 2021) Authors: Sebastian, Shaji; Walker, Gareth J; Kennedy, Nicholas A; Conley, Thomas E; Patel, Kamal V; Subramanian, Sreedhar; Kent, Alexandra J; Segal, Jonathan P; Brookes, Matthew J; Bhala, Neeraj; Gonzalez, Haidee A; Hicks, Lucy C; Mehta, Shameer J; Lamb, Christopher A; Abdale, Shukri; Abbasi, Abdullah; Ab... Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 4(2021) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study. Issue 8 (29th August 2022) Authors: Chanchlani, Neil; Lin, Simeng; Auth, Marcus K.; Lee, Chai Leng; Robbins, Helena; Looi, Shi; Murugesan, Senthil V.; Riley, Tom; Preston, Cathryn; Stephenson, Sophie; Cardozo, Wendy; Sonwalkar, Sunil A.; Allah‐Ditta, Mohammed; Mansfield, Lynne; Durai, Dharmaraj; Baker, Mark; London, Ian; London, Em... Journal: Alimentary pharmacology & therapeutics Issue: Volume 56:Issue 8(2022) Page Start: 1250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. (March 2021) Authors: Alexander, James L; Moran, Gordon W; Gaya, Daniel R; Raine, Tim; Hart, Ailsa; Kennedy, Nicholas A; Lindsay, James O; MacDonald, Jonathan; Segal, Jonathan P; Sebastian, Shaji; Selinger, Christian P; Parkes, Miles; Smith, Philip J; Dhar, Anjan; Subramanian, Sreedhar; Arasaradnam, Ramesh; Lamb, Chri... Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 3(2021) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis. (February 2020) Authors: Perry, Martin; Abdullah, Azhar; Frleta, Marina; MacDonald, Jonathan; McGucken, Andrew Journal: Therapeutic advances in musculoskeletal disease Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis. (February 2020) Authors: Perry, Martin; Abdullah, Azhar; Frleta, Marina; MacDonald, Jonathan; McGucken, Andrew Journal: Therapeutic advances in musculoskeletal disease Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis. (February 2020) Authors: Perry, Martin; Abdullah, Azhar; Frleta, Marina; MacDonald, Jonathan; McGucken, Andrew Journal: Therapeutic advances in musculoskeletal disease Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis. (February 2020) Authors: Perry, Martin; Abdullah, Azhar; Frleta, Marina; MacDonald, Jonathan; McGucken, Andrew Journal: Therapeutic advances in musculoskeletal disease Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗